Azienda Ospedaliera Universitaria Policlinico   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Palermo Italy (1943)

Organization Overview

First Clinical Trial
1999
NCT00381511
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Azienda Ospedaliera Universitaria Policlinico

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Embolism (Phase 4)

Glomerulonephritis (Phase 3)

Glomerulonephritis, Membranous (Phase 3)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis C (Phase 2)

Pulmonary Embolism (Phase 4)

Recurrence (Phase 2)

Respiratory Sounds (Phase 4)

Scleroderma, Diffuse (Phase 2)

Scleroderma, Systemic (Phase 2)

Thrombosis (Phase 4)

Venous Thrombosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 12